Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

SRx Health Solutions (SRXH) Gross Margin (2016 - 2025)

SRx Health Solutions' Gross Margin history spans 10 years, with the latest figure at 29.87% for Q2 2025.

  • For Q2 2025, Gross Margin rose 780.0% year-over-year to 29.87%; the TTM value through Jun 2025 reached 84.49%, up 5999.0%, while the annual FY2024 figure was 57.82%, 2725.0% up from the prior year.
  • Gross Margin reached 29.87% in Q2 2025 per SRXH's latest filing, down from 33.29% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 162.67% in Q4 2024 to a low of 9.33% in Q4 2023.
  • Average Gross Margin over 5 years is 37.56%, with a median of 33.45% recorded in 2025.
  • The largest YoY upside for Gross Margin was 15334bps in 2024 against a maximum downside of -1199bps in 2024.
  • A 5-year view of Gross Margin shows it stood at 25.08% in 2021, then fell by -28bps to 17.94% in 2022, then tumbled by -48bps to 9.33% in 2023, then skyrocketed by 1643bps to 162.67% in 2024, then tumbled by -82bps to 29.87% in 2025.
  • Per Business Quant, the three most recent readings for SRXH's Gross Margin are 29.87% (Q2 2025), 33.29% (Q1 2025), and 162.67% (Q4 2024).